FSNUY Fresenius SE and Company KGaA (PK)

   By Cecilia Butini 
 

Stephan Sturm, chief executive officer of Fresenius SE & Co. KGaA, said in an interview published on the company's website on Tuesday that a sale of Fresenius Medical Care isn't on the up for consideration.

Mr. Sturm said the business's outlook remains positive despite being hit hard by the pandemic. Concerning the company as a whole, management continues to expect healthy growth in sales and earnings this year despite continuing challenges from the pandemic, supply-chain issues and the war in Ukraine, he said.

"We do not have to divest FMC to finance growth in other business segments," the executive said.

Regarding Fresenius' presence in Russia, the executive added that a complete pullout from the country isn't an option as the company is standing by its effort to provide medical care to all people.

Write to Cecilia Butini at cecilia.butini@wsj.com

(END) Dow Jones Newswires

June 07, 2022 12:38 ET (16:38 GMT)

Fresenius SE and Company... (PK) (USOTC:FSNUY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024

Fresenius SE and Company... (PK) (USOTC:FSNUY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024